Aclaris Therapts (ACRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ACRS | ARYD | RVPH | ||
| Company | Aclaris Therapts | Arya Sciences Acquisition Corp IV Cl A | Reviva Pharmaceuticals Hldg Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 1.2000 | 11.33 | 2.97 | ||
| High | 1.2000 | 11.33 | 3.08 | ||
| Low | 1.1600 | 11.33 | 2.94 | ||
| Last | 1.2000 | 11.33 | 2.99 | ||
| Change | +0.0100 | -0.02 | +0.01 | ||
| % Change | +0.84% | -0.18% | +0.34% | ||
| Volume | 445,200 | 15,600 | 116,200 | ||
| 20-Day Average Volume | 739,815 | 25,230 | 183,405 | ||
| Previous Close | 1.1900 | 11.35 | 2.98 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 1.2125 | 11.29 | 3.37 | ||
| 20-Day Raw Stochastic | 33.33% | 70.00% | 8.74% | ||
| 20-Day Relative Strength | 47.98% | 61.49% | 39.72% | ||
| Weighted Alpha | -45.32 | +8.27 | -60.88 | ||
| Today's Opinion | 56% Sell | 100% Buy | 100% Sell | ||
| Previous Opinion | 56% Sell | 100% Buy | 100% Sell | ||
| Last Month's Opinion | 48% Sell | 100% Buy | 64% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.23% since 04/19/24 | +0.27% since 04/12/24 | -0.99% since 04/19/24 | ||
| Low | 1.1400 on 04/25/24 | 11.29 on 04/15/24 | 2.90 on 04/25/24 | ||
| High | 1.2500 on 04/23/24 | 11.39 on 04/24/24 | 3.19 on 04/23/24 | ||
| 1-Month | |||||
| %Chg | +1.69% since 03/26/24 | +0.62% since 03/25/24 | -21.93% since 03/26/24 | ||
| Low | 1.1400 on 04/25/24 | 11.23 on 03/28/24 | 2.90 on 04/25/24 | ||
| High | 1.3200 on 04/01/24 | 11.39 on 04/24/24 | 4.05 on 03/27/24 | ||
| 3-Month | |||||
| %Chg | -2.44% since 01/26/24 | +2.81% since 01/22/24 | -22.74% since 01/26/24 | ||
| Low | 1.0500 on 02/07/24 | 11.02 on 01/30/24 | 2.67 on 03/22/24 | ||
| High | 1.5100 on 03/06/24 | 11.39 on 04/24/24 | 4.83 on 02/13/24 | ||
| 6-Month | |||||
| %Chg | -73.80% since 10/26/23 | +4.42% since 10/19/23 | -21.11% since 10/26/23 | ||
| Low | 0.5902 on 11/13/23 | 10.70 on 11/01/23 | 2.67 on 03/22/24 | ||
| High | 5.7050 on 11/06/23 | 11.39 on 04/24/24 | 6.80 on 10/30/23 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 84,401 | 85,388 | 83,199 | ||
| Shares Outstanding, K | 70,925 | 7,536 | 27,919 | ||
| Annual Sales | 31,250,000 | 0 | 0 | ||
| Annual Net Income | -88,480,000 | -2,130,000 | -39,260,000 | ||
| Last Quarter Sales | 17,570,000 | 0 | 0 | ||
| Last Quarter Net Income | -1,490,000 | -2,220,000 | -9,720,000 | ||
| 60-Month Beta | 0.22 | 0.00 | -0.02 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.30 on 02/27/24 | N/A | -0.35 on 04/15/24 | ||
| Latest Earnings Date | 05/13/24 | N/A | 05/20/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||